European monoclonal antibodies market is estimated to grow at a CAGR of 7.2% during the forecast period. An increasing approval for monoclonal antibodies has been reported in the region, owing to the rising demand for novel monoclonal antibody therapies with higher safety and efficacy in the region. For instance, in June 2020, the European Commission […]
